No official semaglutide to tirzepatide dose conversion exists, but here's how clinicians restart dosing safely when patients switch medications.
There is no FDA-approved semaglutide to tirzepatide dose conversion, and no medical society publishes an official equivalency table. In real clinical practice, most prescribers stop semaglutide and restart tirzepatide at its lowest dose — 2.5 mg once weekly — no matter how high the previous semaglutide dose was, then titrate upward based on tolerance and results.
Any conversion chart you find online is a clinical estimate, not a rule. The switch is about restarting safely, not about matching milligrams.
Is There an Official Semaglutide to Tirzepatide Dose Conversion?
No official conversion exists. The FDA has not approved a dose equivalence between these two medications, and the manufacturers do not publish one.
Semaglutide (Ozempic, Wegovy, Rybelsus) is a GLP-1 receptor agonist. Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist. Because tirzepatide activates two hormone pathways instead of one, its potency per milligram does not map in a straight line onto semaglutide's.
That is why asking for a tirzepatide semaglutide equivalent dose usually returns a range of answers. The honest answer is that the equivalent dose is whatever your prescriber starts you on and then adjusts.
Why the Two Drugs Don't Convert Cleanly
- Different receptor targets: Tirzepatide works on GIP and GLP-1 receptors; semaglutide works on GLP-1 alone.
- Different potency per milligram: 2.5 mg of tirzepatide is not the same as 0.25 mg of semaglutide in effect, even though both are "starting doses."
- Individual response varies: Two people on identical semaglutide doses can respond very differently to the same tirzepatide dose.
- Titration is tolerance-based: Neither drug is dosed to a target blood level, so there is no lab value to convert against.
Because of those differences, switching from semaglutide to tirzepatide generally means starting at the bottom of the tirzepatide dosing ladder rather than continuing at an "equal" dose.
Sample Semaglutide to Tirzepatide Conversion Chart
The table below reflects what many clinicians use as a semaglutide to tirzepatide conversion chart. Treat the right-hand column as a starting point only — your prescriber may choose differently.
| Prior semaglutide weekly dose | Typical tirzepatide starting dose | Notes |
|---|---|---|
| 0.25 mg (starter) | 2.5 mg | Standard restart |
| 0.5 mg | 2.5 mg | Standard restart |
| 1 mg | 2.5 mg | Some clinicians start 5 mg if the prior dose was well tolerated |
| 1.7 mg | 2.5 mg | Standard restart |
| 2 mg | 2.5 mg | Standard restart |
| 2.4 mg (Wegovy maintenance) | 2.5 mg | A minority start at 5 mg; evidence for that approach is limited |
Most people move to 5 mg after four weeks if 2.5 mg is tolerated. Maintenance doses for weight management are commonly 10 mg or 15 mg weekly.
How to Switch From Semaglutide to Tirzepatide in Practice
- Get your prescriber's approval and a new tirzepatide prescription before you stop semaglutide.
- Take your last semaglutide dose, then start tirzepatide about seven days later. Most people do not need a long washout period.
- Inject 2.5 mg once weekly for four weeks.
- Increase stepwise — 5 mg, then 7.5 mg, then 10 mg or 15 mg — in four-week increments only if side effects are manageable.
- Track nausea, appetite, hydration, and bowel habits so you can report changes early.
Step-by-step instructions vary by clinic, so the safest way to learn how to switch from semaglutide to tirzepatide is a direct conversation with the clinician managing your prescription.
Switching From Tirzepatide to Semaglutide
The reverse switch follows the same logic. You do not convert milligrams; you restart semaglutide at 0.25 mg weekly with Wegovy, or 0.5 mg weekly with Ozempic for type 2 diabetes, and titrate up from there.
So can you switch from semaglutide to tirzepatide, or back again? Yes — in most cases a licensed prescriber can change therapy, as long as there are no contraindications such as a history of medullary thyroid carcinoma or pancreatitis.
Oral Semaglutide and Other Formulations
If you take oral semaglutide, a topic people often search as semaglutide tablet dose for weight loss, the same restart-low rule applies. Tablet strength does not translate into a tirzepatide injection dose.
Many patients weighing options also read comparisons of semaglutide vs tirzepatide weight loss, where head-to-head trial data show greater average weight loss with tirzepatide at its highest tolerated doses.
Side Effects and Safety When You Switch
Common side effects of both medications include nausea, vomiting, diarrhea, constipation, and stomach discomfort. These usually ease after a few weeks at a stable dose but can return with each increase.
Serious but rarer risks include pancreatitis, gallbladder disease, bowel obstruction, and dehydration from persistent vomiting. Both drugs carry a boxed warning about thyroid C-cell tumors and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2.
Semaglutide and tirzepatide are not approved for use during pregnancy, and people planning pregnancy are typically advised to stop the medication at least two months before conception.
Do not stack the two drugs. Taking semaglutide and tirzepatide at the same time is not a conversion strategy and raises the risk of severe gastrointestinal side effects.
What to Ask Your Prescriber
- What tirzepatide starting dose do you recommend based on my semaglutide dose and side-effect history?
- How long should I wait between my last semaglutide injection and my first tirzepatide injection?
- What titration schedule should I follow, and which symptoms mean I should call you?
Nothing in this article replaces individualized medical advice from a licensed clinician who knows your history.
Frequently Asked Questions
Can I switch from semaglutide to tirzepatide?
Yes, most prescribers can change your therapy from semaglutide to tirzepatide, provided you have no contraindications. The switch is not a milligram conversion; you typically restart tirzepatide at 2.5 mg once weekly and titrate up. You need a new prescription, so talk to your clinician first.
What is the equivalent dose of tirzepatide to 2.4 mg semaglutide?
There is no established equivalent dose. The FDA has not approved any conversion between the two drugs, and most clinicians restart tirzepatide at 2.5 mg weekly regardless of the prior semaglutide dose. Titration upward depends on how well you tolerate the starting dose.
How long should I wait between my last semaglutide dose and my first tirzepatide dose?
Most clinicians start tirzepatide about seven days after the last semaglutide injection, which lines up with the normal weekly dosing schedule. A longer washout is usually unnecessary, but your prescriber may adjust the timing based on side effects or other conditions.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.